Baculovirus-expressed muscovy duck reovirus $sigma;C protein induces serum neutralizing antibodies and protection against challenge

Vaccine ◽  
2002 ◽  
Vol 20 (25-26) ◽  
pp. 3113-3122 ◽  
Author(s):  
G KUNTZSIMON
2002 ◽  
Vol 83 (5) ◽  
pp. 1189-1200 ◽  
Author(s):  
Gaëlle Kuntz-Simon ◽  
Ghislaine Le Gall-Reculé ◽  
Claire de Boisséson ◽  
Véronique Jestin

Although muscovy duck reovirus (DRV) shares properties with the reovirus isolated from chicken, commonly named avian reovirus (ARV), the two virus species are antigenically different. Similar to the DRV σB-encoded gene (1201 bp long) previously identified, the three other double-stranded RNA small genome segments of DRV have been cloned and sequenced. They were 1325, 1191 and 1124 bp long, respectively, and contained conserved terminal sequences common to ARVs. They coded for single expression products, except the smallest (S4), which contained two overlapping open reading frames (ORF1 and ORF2). BLAST analyses revealed that the proteins encoded by the 1325 and 1191 bp genes shared high identity levels with ARV σA and σNS, respectively, and to a lesser extent with other orthoreovirus counterparts. No homology was found for the S4 ORF1-encoded p10 protein. The 29·4 kDa product encoded by S4 ORF2 appeared to be 25% identical to ARV S1 ORF3-encoded σC, a cell-attachment oligomer inducing type-specific neutralizing antibodies. Introduction of large gaps in the N-terminal part of the DRV protein was necessary to improve DRV and ARV σC amino acid sequence alignments. However, a leucine zipper motif was conserved and secondary structure analyses predicted a three-stranded α-helical coiled-coil feature at this amino portion. Thus, despite extensive sequence divergence, DRV σC was suggested to be structurally and probably functionally related to ARV σC. This work provides evidence for the diversity of the polycistronic S class genes of reoviruses isolated from birds and raises the question of the relative classification of DRV in the Orthoreovirus genus.


Vaccine ◽  
2018 ◽  
Vol 36 (52) ◽  
pp. 8001-8007 ◽  
Author(s):  
Shilong Chen ◽  
Fengqiang Lin ◽  
Shaoying Chen ◽  
Qilin Hu ◽  
Xiaoxia Cheng ◽  
...  

1999 ◽  
Vol 80 (1) ◽  
pp. 195-203 ◽  
Author(s):  
G Le Gall-Recul√© ◽  
M Cherbonnel ◽  
C Arnauld ◽  
P Blanchard ◽  
A Jestin ◽  
...  

2020 ◽  
Vol 52 ◽  
pp. 101575
Author(s):  
Min Zheng ◽  
Xiuqin Chen ◽  
Shao Wang ◽  
Jingxiang Wang ◽  
Meiqing Huang ◽  
...  

2020 ◽  
Vol 276 ◽  
pp. 197806 ◽  
Author(s):  
Minghui Li ◽  
Ping Yan ◽  
Zhenni Liu ◽  
Dongling Cai ◽  
Yu Luo ◽  
...  

2004 ◽  
Vol 78 (4) ◽  
pp. 2017-2028 ◽  
Author(s):  
Jason T. Newman ◽  
Jeffrey M. Riggs ◽  
Sonja R. Surman ◽  
Josephine M. McAuliffe ◽  
Teresa A. Mulaikal ◽  
...  

ABSTRACT Human parainfluenza virus type 1 (HPIV1) is a significant cause of respiratory tract disease in infants and young children for which a vaccine is needed. In the present study, we sought to attenuate HPIV1 by the importation of one or more known attenuating point mutations from heterologous paramyxoviruses into homologous sites in HPIV1. The introduced mutations were derived from three attenuated paramyxoviruses: (i) HPIV3cp45, a live-attenuated HPIV3 vaccine candidate containing multiple attenuating mutations; (ii) the respiratory syncytial virus cpts530 with an attenuating mutation in the L polymerase protein; and (iii) a murine PIV1 (MPIV1) attenuated by a mutation in the accessory C protein. Recombinant HPIV1 (rHPIV1) mutants bearing a single imported mutation in C, any of three different mutations in L, or a pair of mutations in F exhibited a 100-fold or greater reduction in replication in the upper or lower respiratory tract of hamsters. Both temperature-sensitive (ts) (mutations in the L and F proteins) and non-ts (the mutation in the C protein) attenuating mutations were identified. rHPIV1 mutants containing a combination of mutations in L were generated that were more attenuated than viruses bearing the individual mutations, showing that the systematic accretion of mutations can yield progressive increases in attenuation. Hamsters immunized with rHPIV1 mutants bearing one or two mutations developed neutralizing antibodies and were resistant to challenge with wild-type HPIV1. Thus, importation of attenuating mutations from heterologous viruses is an effective means for rapidly identifying mutations that attenuate HPIV1 and for generating live-attenuated HPIV1 vaccine candidates.


2012 ◽  
Vol 163 (2) ◽  
pp. 546-551 ◽  
Author(s):  
Yongfeng Li ◽  
Xiuchen Yin ◽  
Xiaodan Chen ◽  
Xiaojun Li ◽  
Jinzhe Li ◽  
...  

2015 ◽  
Vol 59 (2) ◽  
pp. 282-290 ◽  
Author(s):  
Quanxi Wang ◽  
Yijian Wu ◽  
Yilong Cai ◽  
Yubin Zhuang ◽  
Lihui Xu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document